Torrent Pharmaceuticals

Price chart

Previous close

₹4,773.00

Open

₹4,792.50

Day high

₹4,835.00

Day low

₹4,735.90

Listed on NSE since 25 November 2002.

Futures and options

Futures, 23 Nov expiry

₹4,760.80

Premium to the share price

+18.30 (+0.39%)

Futures open interest

26,999 contracts (−38 today)

Lot size (NOV 26)

125 shares

Source: NSE, 09-Nov-2026 12:04:27, delayed. Option chain · All futures · Lot sizes

Pivot levels

R3

4,883.70

R2

4,836.60

R1

4,793.30

CPR top

4,748.10

Pivot

4,746.20

CPR bottom

4,744.30

S1

4,702.90

S2

4,655.80

S3

4,612.50

From Friday 6 November’s high, low and close (Yahoo Finance). Arithmetic on past prices, not a forecast.

Market value

₹1,81,424 Cr

P/E (trailing)

80.57

EPS (trailing)

₹59.20

Price to book

9.87

Dividend yield

0.80%

Return on equity

15.7%

Debt to equity

0.77

Profit margin

12.2%

Beta

0.17

Volume today

1.34 L

Average volume

3.32 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Torrent Pharmaceuticals’s results filed with NSE, consolidated (the whole group). Net profit is the share of Torrent Pharmaceuticals’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Torrent Pharmaceuticals’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Ahmedabad

Employees

18,258

Company website · Profile: Yahoo Finance

No headlines name Torrent Pharmaceuticals in the last day or two.

• Dividend - Rs 9 Per Share

  Dividend · ex-date 29 May 2026

• Interim Dividend - Rs 29 Per Share

  Dividend · ex-date 18 February 2026 · record date 19 February 2026

• Dividend - Rs 6 Per Share

  Dividend · ex-date 20 June 2025

• Interim Dividend - Rs 26 Per Sh

  Dividend · ex-date 31 January 2025 · record date 1 February 2025

• Dividend - Rs 6 Per Share

  Dividend · ex-date 21 June 2024

• Interim Dividend - Rs 22 Per Share

  Dividend · ex-date 12 February 2024

• Dividend - Rs 8 Per Share

  Dividend · ex-date 23 June 2023

• Interim Dividend - Rs 14 Per Share

  Dividend · ex-date 3 February 2023

Source: NSE. Latest first, 8 of 20.